Conference Coverage
Even with no disease activity, recurrence risk near 50% when stopping DMTs for MS
STOCKHOLM – Younger patients had a significantly higher risk of recurrence when stopping disease modifying therapy.
Conference Coverage
Plasma exchange in natalizumab-related PML shows no benefit, possible harm
STOCKHOLM – Biggest-ever study of natalizumab-associated PML in patients with multiple sclerosis raises red flag regarding common practice of...
Conference Coverage
Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomide
STOCKHOLM – The monoclonal antibody reduced annualized relapse rate and the risk of confirmed disability worsening,...
Conference Coverage
Average daily step count reflects disability in MS
STOCKHOLM – Step count can be monitored remotely and correlates with measures of walking performance, cognitive...
Conference Coverage
In highly active MS, is skipping gadolinium an option?
STOCKHOLM – Though skipping contrast missed a small number of lesions, most patients would still have been classified and treated correctly.
Conference Coverage
Most patients with RIS develop MS within 10 years
STOCKHOLM – The conversion rate jumps to 87% in the presence of four risk factors at baseline.
Conference Coverage
In MS, iron-ringed lesions may add to imaging toolkit
STOCKHOLM – Brain lesions with iron rings were detected only in MRI scans of MS patients.
Conference Coverage
Ponesimod reduces annualized relapse rate, compared with teriflunomide
STOCKHOLM – The investigational MS treatment is superior to the approved drug on measures of fatigue and active...
Conference Coverage
Continuous treatment reduces risk of confirmed disability progression in MS
STOCKHOLM – The risk of confirmed disability progression appears to decrease with increasing length of continuous...
Conference Coverage
Neurologists need not discourage breastfeeding in women with MS
STOCKHOLM – For women with MS who want to breastfeed and have more active disease where early treatment resumption is warranted, the key is to...
News
Vaccination is not associated with increased risk of MS
Data indicate an association between vaccination and lower likelihood of incident MS, but do not support conclusions about whether vaccination has...
News
Obesity tied to relapse in young patients with multiple sclerosis
Weight loss or BMI-based dosing might improve treatment response.
Conference Coverage
Black holes are associated with impaired cognition in MS
SEATTLE – Patients with MS and at least one black hole have poorer cognitive processing speed and visuospatial...
Conference Coverage
Functional GI disorders are common in MS
SEATTLE – In patients with MS, the prevalence of functional GI disorders increases with increasing disability.
Conference Coverage
Neutrophils may decline in patients on fingolimod
SEATTLE – Levels of these innate immune cells decreased in patients who had been on the drug for years, and this finding warrants further research...
Conference Coverage
Age does not influence cladribine’s efficacy in MS
SEATTLE – Cladribine provides comparable reductions in relapse rate and new lesions to patients with relapsing-...
Video
Patient registry sheds light on the economic impact of MS
SEATTLE – Dr. Kottil Rammohan discusses the extent to which multiple sclerosis limits patients’ potential at work and at home.
Conference Coverage
-
Even with no disease activity, recurrence risk near 50% when stopping DMTs for MS -
-
Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomide -
Average daily step count reflects disability in MS -
Multimedia
Question 1 of 5